about
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genesNo evidence for involvement of SDHD in neuroblastoma pathogenesisCombined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA ampliconsPositional and functional mapping of a neuroblastoma differentiation gene on chromosome 11arrayCGHbase: an analysis platform for comparative genomic hybridization microarrays.Focal DNA copy number changes in neuroblastoma target MYCN regulated genesDickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastomaA detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell linesEvaluation of qPCR curve analysis methods for reliable biomarker discovery: bias, resolution, precision, and implicationsThe von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastomaA p53 drug response signature identifies prognostic genes in high-risk neuroblastomaApplication of laser capture microdissection in genetic analysis of neuroblastoma and neuroblastoma precursor cells.Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genesCADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23External oligonucleotide standards enable cross laboratory comparison and exchange of real-time quantitative PCR data.Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples.Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastomaActivated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization.Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastomaAccurate prediction of neuroblastoma outcome based on miRNA expression profiles.N-cadherin in neuroblastoma disease: expression and clinical significance.Cancer gene prioritization for targeted resequencing using FitSNP scoresUnequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.ViVar: a comprehensive platform for the analysis and visualization of structural genomic variationDifferent Sarcocystis spp. are present in bovine eosinophilic myositis.Genome wide expression profiling of p53 regulated miRNAs in neuroblastomaMYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation.A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies.Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomasGenome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma.MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastomaDetection of DNA copy number alterations in cancer by array comparative genomic hybridization.ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours.Copy number alterations and copy number variation in cancer: close encounters of the bad kind.Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cells.Targeting tachykinin receptors in neuroblastoma.
P50
Q24534395-CF97FE8E-20D5-4607-99A5-24E28C682FE3Q24791722-5F2D7044-BCB4-4A3B-84C8-13AA5EE4981AQ24799947-A5F88C9E-94AD-4AF0-B6B2-BDEECB297034Q24812698-D2228F8D-DDCA-43CC-B8E5-FC85A20A15F6Q24815397-98007693-94B2-4AA9-8359-B07270D61EB3Q28115604-668C358D-5529-456D-81D2-4E849877840BQ28117269-944B5DE9-66B4-4A22-A288-8CA2C652675CQ28235071-6DD68CC4-A97F-4D2D-BA32-D0D981C6100DQ28274988-95C6727A-E0C5-40F0-9820-777074DFFA41Q28299521-3ADB4CCB-4786-458B-9B9F-F3C4868CFB29Q28537647-566B0171-BAAA-4DF0-8EBC-3EC05D3CA6C6Q31150767-9B1DB2A8-DCDD-439F-98AA-6CBA11E80010Q33258311-86057268-C717-42DE-8B02-2B2D2DCCD59DQ33344256-35DAFD9C-C9A7-4267-8A11-47E4B7C28623Q33500566-ADCB426C-1AAC-41A3-A249-07FEEECC9E91Q33533707-24E2B21E-6862-4432-8DF6-22DF710DD2B0Q33559546-9DC99F31-553A-401B-9D12-E37350B0CA7AQ33575683-2CACBD17-DD61-48C8-A209-54E3C5D04F85Q33757079-4030B047-3C76-4508-9E71-5731727E331DQ33870055-BCF9C1E6-FB27-4EFF-ADD5-F6911C4CD30DQ33891984-6A142FE6-0DF8-4B48-B3C5-23DDB6533FACQ34115726-A8E2E897-7F41-411A-BD58-DCDDEC4C09DFQ34166281-509609E0-784E-41C0-A8D6-089AC69EE569Q34187077-59178C4D-F88E-48D6-A9B0-72A73801B3CDQ34407560-81990ABA-A188-4988-9D0B-63E9390C418FQ34606771-B4E086EA-029D-4FEA-945C-CCDFA76E3591Q34689307-17D33DBE-9B8D-4662-8180-8902C37C5ECEQ34840635-83AD7001-C14A-4F57-9C74-C900A3A4B225Q35169491-3B1ABD2A-41B9-4227-97DF-1272A2DD70D0Q35741642-ABFCE155-098D-4574-B8A2-9077F5254457Q35804064-87524AE0-DDB3-4CAA-8F1F-5EE8CD8D85DDQ36048192-A3A03610-72B6-48CB-AA06-45C5505476ACQ36378134-E72C39F7-5BBF-4EE2-8C1A-CD8E3069A339Q36739006-265013CA-3D87-440E-A07A-A99ECAE3ECF7Q36815139-3F3EE0F9-7DF3-4D94-A173-B34D1862834EQ36943634-7E38F133-7270-49B7-8251-584B08C55D78Q37154010-0720060B-A1C1-4014-B989-FAB4AAE9988EQ37415175-BB6C61AD-4D03-4A9B-967E-BA7A942CD6E3Q37688783-BF8E7130-05B7-4067-B2DD-D91D091D1FA9Q37702248-7E0A1D18-015A-40DA-B92D-3C7835EE96C9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Katleen De Preter
@ast
Katleen De Preter
@en
Katleen De Preter
@es
Katleen De Preter
@fr
Katleen De Preter
@nl
Katleen De Preter
@sl
type
label
Katleen De Preter
@ast
Katleen De Preter
@en
Katleen De Preter
@es
Katleen De Preter
@fr
Katleen De Preter
@nl
Katleen De Preter
@sl
prefLabel
Katleen De Preter
@ast
Katleen De Preter
@en
Katleen De Preter
@es
Katleen De Preter
@fr
Katleen De Preter
@nl
Katleen De Preter
@sl
P1053
I-7135-2013
P106
P21
P31
P3829
P496
0000-0002-7726-5096